 | Steven Prestrelski Sells 27,700 Shares of Xeris Pharmaceuticals Inc (NASDAQ:XERS) Stock
www.americanbankingnews.com - October 17 at 7:38 PM |
 | Xeris Pharmaceuticals Appoints Mark Thierer to Board of Directors
finance.yahoo.com - October 1 at 8:07 AM |
| Xeris Pharmaceuticals Inc (NASDAQ:XERS) Short Interest Up 17.2% in September
www.americanbankingnews.com - September 27 at 1:13 AM |
 | FDA OKs Xeris Pharma's glucagon for severe low blood sugar in diabetics
seekingalpha.com - September 10 at 4:48 PM |
 | Great News for Patients With Dangerously Low Blood Sugar
247wallst.com - September 10 at 4:48 PM |
| UPDATE 2-Xeris Pharma's low blood sugar treatment wins FDA approval
finance.yahoo.com - September 10 at 4:48 PM |
| Xeris Pharmaceuticals Receives U.S. FDA Approval for GVOKE™ (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia
finance.yahoo.com - September 10 at 11:38 AM |
| Xeris Pharmaceuticals Announces Expanded $85 Million Debt Facility With Oxford Finance and Silicon Valley Bank
finance.yahoo.com - September 10 at 11:38 AM |
 | The Week Ahead In Biotech: Conference Presentations, IPO News Flow Take The Spotlight
feeds.benzinga.com - September 8 at 12:40 PM |
| Xeris Pharmaceuticals (XERS) Presents At 2019 Wells Fargo Healthcare Conference - Slideshow
seekingalpha.com - September 7 at 8:53 AM |
| Xeris: Preparing For The Gvoke PDUFA
seekingalpha.com - September 7 at 8:53 AM |
| Have Insiders Been Buying Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) Shares?
finance.yahoo.com - September 4 at 4:00 PM |
| Xeris Pharmaceuticals to Present at Two September Healthcare Conferences
finance.yahoo.com - August 29 at 9:04 PM |
| Xeris Pharmaceuticals EPS misses by $0.32, beats on revenue
seekingalpha.com - August 6 at 9:12 PM |
| Xeris Pharmaceuticals Announces Second Quarter 2019 Financial Results and Highlights
finance.yahoo.com - August 6 at 9:12 PM |
| Xeris Pharmaceuticals, Inc. (XERS) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 6 at 9:12 PM |
| Xeris Pharmaceuticals, Inc. (XERS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - August 5 at 11:25 AM |
| Did Changing Sentiment Drive Xeris Pharmaceuticals's (NASDAQ:XERS) Share Price Down By 38%?
finance.yahoo.com - July 18 at 3:49 PM |
| Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its Developmental Ready-to-use Glucagon in Patients at Risk From Hypoglycemia Following Bariatric Surgery
finance.yahoo.com - June 27 at 3:49 PM |
 | XERIS PHARMACEUTICALS INC
www.finanznachrichten.de - June 17 at 11:12 PM |
| Xeris reports positive trial results for RTU glucagon in hypoglycemia
seekingalpha.com - June 17 at 12:48 PM |
| Xeris Pharmaceuticals Announces Additional Positive Outcomes from a Global Phase 3 Clinical Trial of Its Investigational Ready-to-Use Glucagon
finance.yahoo.com - June 17 at 12:48 PM |
| Xeris: Gvoke PDUFA Gets Delayed And Creates Buying Opportunity
seekingalpha.com - June 11 at 12:07 PM |
| FDA extends action date 90 days for Xeris Pharma's glucagon rescue pen
seekingalpha.com - June 7 at 5:17 PM |
 | Xeris Pharmaceuticals Receives Notification of PDUFA Date Extension for Gvoke™
www.nasdaq.com - June 7 at 5:17 PM |
| Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
feeds.benzinga.com - May 31 at 1:54 PM |
| Can We See Significant Institutional Ownership On The Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) Share Register?
finance.yahoo.com - May 25 at 11:22 AM |
| Xeris Pharmaceuticals Announces First Quarter 2019 Financial Results and Highlights Its Pipeline
finance.yahoo.com - May 10 at 11:59 AM |
| Xeris Pharmaceuticals Announces Results From a Phase 1 Study of Its Novel Formulation of Diazepam
finance.yahoo.com - May 1 at 11:34 AM |
| Our Prognosis On Xeris
seekingalpha.com - April 8 at 4:16 PM |
| Xeris up 1% on positive room-temp glucagon data
seekingalpha.com - March 25 at 12:13 PM |
 | Xeris Pharmaceuticals Presents New Clinical and Economic Impact Data on Its Developmental Ready-to-Use Glucagon
www.marketwatch.com - March 25 at 12:13 PM |
| Mid-stage study of Xeris Pharma's ready-to-use glucagon underway
seekingalpha.com - March 15 at 12:22 PM |
| Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its Ready-to-Use Glucagon to Address Exercise-Induced Hypoglycemia
finance.yahoo.com - March 15 at 12:22 PM |
| Wednesday 3/13 Insider Buying Report: XERS, ATEC
www.nasdaq.com - March 13 at 11:47 AM |
| How Many Insiders Bought Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) Shares?
finance.yahoo.com - March 12 at 7:00 PM |
| Xeris: Looking For Entry Before PDUFA
seekingalpha.com - March 7 at 12:43 PM |
| Xeris Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline Progress
finance.yahoo.com - March 7 at 12:43 PM |
| Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - March 2 at 11:24 AM |
| Xeris Pharma down 9% premarket on stock offering
seekingalpha.com - February 14 at 11:45 AM |
| Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock
finance.yahoo.com - February 14 at 11:45 AM |
| Mid-Day Market Update: Dow Rises Over 300 Points; Bristow Group Shares Plummet
www.nasdaq.com - February 12 at 3:45 PM |
 | Xeris Pharmaceuticals Inc.
www.barrons.com - February 12 at 12:09 PM |
| Xeris Pharmaceuticals Announces Proposed Public Offering of Shares of Common Stock
finance.yahoo.com - February 12 at 12:09 PM |
| The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares
finance.yahoo.com - February 12 at 12:09 PM |
 | Nora Brennan Joins TELA Bio® as Chief Financial Officer
www.bizjournals.com - January 2 at 10:47 AM |
| Xeris Pharma's liquid glucagon an Orphan Drug is Europe for rare insulin disorder
seekingalpha.com - December 20 at 3:31 PM |
| European Medicines Agency Grants Orphan Drug Designation for Xeris’ Investigational Ready-to-Use Glucagon for the Treatment of Non-Insulinoma Pancreatogenous Hypoglycaemia Syndrome (NIPHS)
finance.yahoo.com - December 20 at 10:36 AM |
| Xeris Pharmaceuticals Releases Additional Phase 3 Clinical Trial Data on Its Ready-to-Use Liquid Glucagon Pen
www.bizjournals.com - November 12 at 3:23 PM |
| Xeris Pharmaceuticals Announces Third Quarter 2018 Financial Results and Highlights Pipeline Progress
finance.yahoo.com - November 7 at 8:46 AM |
